| 0.6739 -0.106 (-13.54%) | 10-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1  |
1-year : | 1.15 |
| Resists | First : | 0.86 |
Second : | 0.99 |
| Pivot price | 0.79 |
|||
| Supports | First : | 0.65 |
Second : | 0.54 |
| MAs | MA(5) : | 0.76 |
MA(20) : | 0.81 |
| MA(100) : | 1.05 |
MA(250) : | 1.19  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 20.8 |
D(3) : | 23.5 |
| RSI | RSI(14): 26.6 |
|||
| 52-week | High : | 3.08 | Low : | 0.25 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TVGN ] has closed below the lower bollinger band by 21.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 20.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.79 - 0.8 | 0.8 - 0.8 |
| Low: | 0.64 - 0.64 | 0.64 - 0.65 |
| Close: | 0.67 - 0.67 | 0.67 - 0.68 |
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Fri, 26 Sep 2025
Tevogen Bio Holdings receives Nasdaq notice for minimum bid price deficiency - Investing.com
Fri, 26 Sep 2025
Tevogen Bio Faces Nasdaq Delisting Notice - TipRanks
Tue, 23 Sep 2025
20M Americans Affected: Tevogen's T Cell Therapy TVGN 489 Shows Breakthrough in Long COVID Treatment - Stock Titan
Tue, 23 Sep 2025
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID - GlobeNewswire
Sat, 20 Sep 2025
When Will Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Turn A Profit? - simplywall.st
Fri, 19 Sep 2025
Tevogen Commends HHS for Addressing Long COVID, Emphasizes - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 197 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 79.3 (%) |
| Held by Institutions | 2.5 (%) |
| Shares Short | 2,590 (K) |
| Shares Short P.Month | 3,250 (K) |
| EPS | -0.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.1 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -515.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.16 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -3.55 |
| PEG Ratio | 0 |
| Price to Book value | -7.49 |
| Price to Sales | 0 |
| Price to Cash Flow | -9.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|